New hope for tough cancers: first human trial of experimental drug begins
Disease control
Not yet recruiting
This is the first time researchers are testing the experimental drug ISM5939 in people. The study aims to find a safe and effective dose for patients with advanced or metastatic solid tumors that have stopped responding to standard treatments. Researchers will first test the drug…
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC